HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Proteome

Cancer Proteome

Exploring the labyrinth of the cancer proteome stands as a cornerstone in oncological exploration, unraveling the molecular intricacies orchestrating tumorigenesis and therapeutic avenues. By delving into the complete protein repertoire within cancerous cells, scientists decode the interplay, mutations, and impact of these proteins on cellular dynamics. This profound comprehension paves the way for tailored treatments aimed at disrupting specific cancer-driving pathways. Moreover, the cancer proteome illumination unveils the heterogeneous nature of tumors, facilitating subtype categorization and bespoke therapeutic strategies. With advancements like mass spectrometry and bioinformatics, our comprehension of the cancer proteome deepens, heralding a new era of precision and personalized cancer management.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp